Skip to main content
. 2008 Sep;19(9):1827–1835. doi: 10.1681/ASN.2007050622

Table 2.

Characteristics of the 66 patients with ESRD as a function of AoC status

Variable AoC Negative(n = 18) AoC Positive(n = 48) P
Age (yr; mean ± SEM) 32.80 ± 2.50 53.60 ± 1.40 <0.00010
Aortic PWV (m/s; mean ± SEM) 8.48 ± 0.38 11.63 ± 0.35 <0.00010
Smoking (pack-years; median [95% CI]) 0.00 (0.00 to 5.00) 5.00 (1.00 to 15.00) <0.01000
Vintage (mo; mean ± SEM) 59.00 ± 7.90 94.00 ± 9.10 0.01000
SBP (mmHg; mean ± SEM) 151.00 ± 6.20 158.00 ± 3.10 NS
DBP (mmHg; mean ± SEM) 86.00 ± 3.80 86.00 ± 1.80 NS
Total cholesterol (mmol/L; mean ± SEM) 4.87 ± 0.30 5.18 ± 0.16 NS
Serum albumin (g/L; mean ± SEM) 40.80 ± 0.40 37.90 ± 0.30 <0.00010
CRP (mg/L) 2.00 (1.00 to 3.00) 8.00 (7.00 to 10.00) <0.00010
Serum Ca (mmol/L; mean ± SEM) 2.40 ± 0.04 2.43 ± 0.02 NS
Ionized Ca (mmol/L; mean ± SEM) 1.23 ± 0.01 1.21 ± 0.01 NS
Serum PO4 (mmol/L; mean ± SEM) 1.81 ± 0.06 2.06 ± 0.06 <0.01000
Ca*PO4 (mmol2/L2; mean ± SEM) 4.35 ± 0.17 5.00 ± 0.15 <0.01000
PTH (pg/ml; median [95% CI]) 411.00 (229.00 to 670.00) 206.00 (160.00 to 291.00) <0.00001
Serum Al (μ mol/L; mean ± SEM) 0.96 ± 0.13 1.62 ± 0.14 <0.01000
Deferoxamine test (ΔAl μ mol/L; mean ± SEM) 1.48 ± 0.26 2.70 ± 0.24 <0.01000
CaCO3 (g of elemental Ca/d; mean ± SEM) 1.270 ± 0.300 1.900 ± 0.132 0.02000
1α-OH-D3 (μ g/wk; median [95% CI]) 0.25 (0.00 to 0.50) 0.00 (0.00 to 0.25) NS
Resorption surfaces (%; median [95% CI]) 2.56 (1.71 to 3.85) 0.68 (0.27 to 1.40) <0.00100
Osteoclasts/mm2 (median [95% CI]) 1.70 (1.05 to 2.70) 0.47 (0.28 to 1.00) <0.00100
Osteoblastic surfaces (%; median [95% CI]) 13.00 (10.20 to 15.20) 3.40 (1.20 to 7.30) <0.00100
Double tetracycline–labeled surfaces (%; median [95% CI]) 15.00 (9.00 to 18.50) 1.30 (0.00 to 3.20) <0.00100
Al-stained surfaces (%; median [95% CI]) 0.00 (0.00 to 7.50) 28.50 (17.00 to 50.30) <0.01000
Post-PTX hypoparathyroidism (yes/no) (n) 0/18 8/40 <0.01000